Media Reports, page-33

Skinza, wheezo’s reduction from $299 to $99 is definitely addressing your and your doctors concerns about the costs in certain demographics.
RSH is an e-Health SaaS company and therefore a software licensing and delivery model in which software is licensed on a subscription basis - $9.99 per month. This will be THE Revenue maker particularly from long term clients.

I also imagine wheezo would have to proof it’s usefulness and benefits in the market place, getting approval and support from Asthma Australia and other similar institutions first, before government funding could become a possibility.

As for the change from Zip to Openpay - in my opinion you go with the best deal offered!

Hang in there Skinza, you are in good hands!

Cheers